Blog: A do-it-yourself treatment program for cancer survivors
March 22, 2011
Blog: Hair, Glorious Hair
March 22, 2011 – Kathy LaTour
Words of Wisdom
March 21, 2011
Chilling Hair News
March 21, 2011 – Kathy LaTour
Videos from Yoga Bear
March 21, 2011
JourneyForward.org
March 16, 2011 – Elizabeth Whittington
Herb Could Work Against Advanced Breast Cancer
March 16, 2011 – Kathy LaTour
Transplants More Effective for Young Adults with AML
March 15, 2011 – Elizabeth Whittington
Predicting Colorectal Cancer Recurrence
March 15, 2011 – Elizabeth Whittington
Yoga by Any Other Name
March 03, 2011
Cancer: The Change I Cherish
March 11, 2011
CA-125: What the Numbers Tell Us
March 03, 2011 – Lindsay Ray
Origins of Ovarian Cancer
March 03, 2011 – Renée Twombly
A Primer on How Faster Approval Works
March 03, 2011 – Mike King
Reclaim Your Brain
March 03, 2011 – Staff Reports
The Legal Side of Chemobrain
March 03, 2011 – Kathy LaTour
Mining Cancer Data in the Molecular Age
March 03, 2011 – Mike King
Expecting the Unexpected
March 03, 2011 – Don Vaughan
Bending the Rules
March 03, 2011 – Claudia M. Caruana
Sifting
March 03, 2011 – Janet Filips
The Emperor of All Maladies: A Biography of Cancer
March 03, 2011 – Kathy LaTour
Q & A: Medicare and Advance Care Planning
March 03, 2011 – Len Lichtenfeld, MD
Know Your Rights
March 03, 2011
Favre Visits Pediatric Patient
March 03, 2011 – Lindsay Ray
Jumping on the Ban Wagon
March 03, 2011 – Lindsay Ray
Pipeline
March 03, 2011 – Staff Reports
The Fragile Bonds of Cancer
March 02, 2011 – Richard C. Frank
The Machine and Me
March 02, 2011 – Ginny Vroblesky
A Mouth Full
March 02, 2011 – Lacey Meyer
Overhauling Clinical Trials
March 02, 2011 – Laura Beil
Hitting Hard-to-Treat Cancers
March 02, 2011 – Mike King
Fighting Back
March 02, 2011 – Lindsay Ray
Letters From Our Readers
March 14, 2011
What is the Benefit, Precisely?
March 02, 2011 – Debu Tripathy, MD
Breaking Out of the Silence
March 02, 2011 – Renée Twombly
Hurdles on the Faster Track
March 02, 2011 – Mike King
Lifting the Fog on Chemobrain
March 02, 2011 – Elaine Schattner, MD
Blog: A do-it-yourself treatment program for cancer survivors
March 22, 2011
Blog: Hair, Glorious Hair
March 22, 2011 – Kathy LaTour
Words of Wisdom
March 21, 2011
Chilling Hair News
March 21, 2011 – Kathy LaTour
Videos from Yoga Bear
March 21, 2011
JourneyForward.org
March 16, 2011 – Elizabeth Whittington
Herb Could Work Against Advanced Breast Cancer
March 16, 2011 – Kathy LaTour
Transplants More Effective for Young Adults with AML
March 15, 2011 – Elizabeth Whittington
Predicting Colorectal Cancer Recurrence
March 15, 2011 – Elizabeth Whittington
Yoga by Any Other Name
March 03, 2011
Cancer: The Change I Cherish
March 11, 2011
CA-125: What the Numbers Tell Us
March 03, 2011 – Lindsay Ray
Origins of Ovarian Cancer
March 03, 2011 – Renée Twombly
A Primer on How Faster Approval Works
March 03, 2011 – Mike King
Reclaim Your Brain
March 03, 2011 – Staff Reports
The Legal Side of Chemobrain
March 03, 2011 – Kathy LaTour
Mining Cancer Data in the Molecular Age
March 03, 2011 – Mike King
Expecting the Unexpected
March 03, 2011 – Don Vaughan
Bending the Rules
March 03, 2011 – Claudia M. Caruana
Sifting
March 03, 2011 – Janet Filips
The Emperor of All Maladies: A Biography of Cancer
March 03, 2011 – Kathy LaTour
Currently Viewing
Q & A: Medicare and Advance Care Planning
March 03, 2011 – Len Lichtenfeld, MD
Favre Visits Pediatric Patient
March 03, 2011 – Lindsay Ray
Jumping on the Ban Wagon
March 03, 2011 – Lindsay Ray
Pipeline
March 03, 2011 – Staff Reports
The Fragile Bonds of Cancer
March 02, 2011 – Richard C. Frank
The Machine and Me
March 02, 2011 – Ginny Vroblesky
A Mouth Full
March 02, 2011 – Lacey Meyer
Overhauling Clinical Trials
March 02, 2011 – Laura Beil
Hitting Hard-to-Treat Cancers
March 02, 2011 – Mike King
Fighting Back
March 02, 2011 – Lindsay Ray
Letters From Our Readers
March 14, 2011
What is the Benefit, Precisely?
March 02, 2011 – Debu Tripathy, MD
Breaking Out of the Silence
March 02, 2011 – Renée Twombly
Hurdles on the Faster Track
March 02, 2011 – Mike King
Lifting the Fog on Chemobrain
March 02, 2011 – Elaine Schattner, MD

Q & A: Medicare and Advance Care Planning

Should Medicare pay for advance care planning?

BY Len Lichtenfeld, MD
PUBLISHED March 03, 2011

Q: How does the absence of end-of-life discussions affect cancer patients covered under Medicare? 

A: Getting Medicare payment for end-of-life discussions between patients, families and health professionals has not gone well.  

When legislators and regulators tried to encourage these discussions and move to a more patient-centered culture, they were met with cries of “death panels.” The resulting firestorm of protests prompted lawmakers to withdraw the proposals.

As a physician, I can’t think of a more important subject. We doctors have less difficulty talking about diagnoses, treatments and procedures than we do about the prospect of further treatment offering little benefit and perhaps even causing more harm than good. Ultimately, it’s the patient’s wishes that count. If health care professionals don’t bring it up, how is the patient to know?

We have a culture in this country that is geared toward success. Many people believe the next miracle is just around the corner. Although miracles do happen, more often they don’t. This hope may rob patients of their last days—feeling ill from treatment and in the hospital instead of at home with family and friends.

Recent research has proven that early palliative care integrated with standard care for lung cancer patients receiving chemotherapy can actually prolong life. Palliative care specialists are comfortable with having these difficult discussions with their patients, whereas many oncologists and primary care physicians aren’t.

We tend to look death in the eye and say it won’t happen to us. But it will happen to us—all of us. Taking the time to talk with your family and your care team to let them know what you want done if you aren’t able to make a decision is just as important as having a discussion about your next surgery, radiation or chemotherapy treatment. I would go so far as to say it is more important because your opinions about your mortality will guide many of the decisions you make during your care.

Thinking about that question is not embracing a “death panel”—an insult to the many patients, families and physicians who have talked about their wishes and made those difficult choices.  

Understanding what you want done—and how you choose to face your illness and its treatment—is good medicine, good care and good for you and your family.

—Len Lichtenfeld, MD, is deputy chief medical officer for the American Cancer Society.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In